SKI Market

A+| A| A-|

Indian Indices

Sensex

76,913.50 -582.86
( -0.75%)

Global Indices

Nasdaq

49,530.46 -142.69
(-0.29%)

Dow Jones

7,252.74 22.73
(0.31%)

Hang Seng

59,594.47 309.55
(0.52%)

Nikkei 225

10,375.34 -3.48
(-0.03%)

Forex

USD-INR

94.96 0.17
(0.17%)

EUR-INR

111.11 0.25
(0.23%)

GBP-INR

128.48 0.55
(0.43%)

JPY-INR

0.60 0.01
(1.28%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

539730

INE194R01017

465.1938745

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

36.12

1229.83

EPS(TTM)

Face Value()

Div & Yield %

61.76

0.03

Back

Ratnamani Metals & Tubes consolidated net profit declines 16.34% in the December 2025 quarter

Feb 06,2026

Net profit of Ratnamani Metals & Tubes declined 16.34% to Rs 109.85 crore in the quarter ended December 2025 as against Rs 131.31 crore during the previous quarter ended December 2024. Sales declined 19.03% to Rs 1065.83 crore in the quarter ended December 2025 as against Rs 1316.30 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	1065.83	1316.30	-19
OPM %	19.21	15.49	-
PBDT	228.50	215.06	6
PBT	195.28	188.12	4
NP	109.85	131.31	-16

76,913.50 -582.86 ( -0.75%)

49,530.46 -142.69 (-0.29%)

7,252.74 22.73 (0.31%)

59,594.47 309.55 (0.52%)

10,375.34 -3.48 (-0.03%)

94.96 0.17 (0.17%)

111.11 0.25 (0.23%)

128.48 0.55 (0.43%)

0.60 0.01 (1.28%)